Abiopharma

🔍 Eswaran Anand (Director)

Company: F5, INC. (FFIV)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 916 shares of Restricted Stock Unit (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 916.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.
• F2: Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2026 (to be held in 2027) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.
• F3: If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.